# Tesamorelin

> Source: https://www.auspeptidewarehouse.com.au/products/tesamorelin
> SKU: APW-TESA
> Category: Metabolic Research
> Last verified: 2026-06-05
> License: RSL-1.0 | AI-Usage: cite-with-attribution

## Quick Facts

| Attribute | Value |
|---|---|
| Product | Tesamorelin |
| Specification | 10mg - Lyophilized |
| Purity (HPLC) | 99.022% |
| Price (AUD) | $139.99 |
| Availability | InStock |
| Manufactured | GMP-certified facility |
| Tested by | Janoshik Analytical (independent third-party) |
| Ships from | Melbourne, Australia |

## Variants

| Variant | Price (AUD) |
|---|---|
| 10mg | $129.99 |
| 20mg | $229.99 |

## Description

Research-grade Tesamorelin 10mg lyophilised powder — 99.1% HPLC purity, COA verified. Stabilised GHRH analogue studied for visceral fat reduction, body recomposition, and GH/IGF-1 axis research. Distinct mechanism from GLP-1 compounds — works via endogenous GH stimulation.

## Detailed Overview

**Growth Hormone Axis and Visceral Adipose Research**

Tesamorelin is available in Australia from Peptide Warehouse Australia with fast domestic shipping to all states and territories.

Tesamorelin is a stabilised analogue of the hormone the body naturally produces to trigger growth hormone (GH) release from the pituitary gland. Unlike GLP-1 receptor agonists, which act on incretin pathways, Tesamorelin works through an entirely different mechanism — it stimulates the body's own growth hormone axis, which in turn is studied for downstream lipid-metabolism pathways. Researchers are particularly interested in its activity at the GHRH receptor, making it a distinct and complementary research tool to the GLP-1 class.

**What Tesamorelin Is Studied For**

**Visceral adipose tissue biology** — The most studied application: GH-stimulated lipolysis pathways in deep abdominal tissue, investigated in randomised Phase 3 trials (Falutz et al., NEJM 2007).
**Body composition research** — GH-driven IGF-1 production is studied for its role in lean-tissue and lipid-distribution pathways.
**GH axis research** — Used when researchers need to study the GHRH receptor pathway with the closest possible match to the body's own natural hormone signal.
**CNS IGF-1 research** — Emerging research on brain-region IGF-1 elevation and its role in neuronal biology in preclinical ageing models.

⚠ For in-vitro laboratory research use only. Not approved for human or veterinary use. Not drugs, food supplements, or cosmetics. Not evaluated or approved by the TGA. You must be 18 years of age or older to purchase. By placing this order, you confirm you are a qualified researcher and will use this compound strictly in accordance with all applicable Australian laws and regulations.

## Research Applications

- Studied for GH-stimulated lipolysis pathways in adipose-tissue research
- Works via endogenous GH stimulation — distinct mechanism from GLP-1 compounds
- 99.1% HPLC purity — independently verified
- Full COA with mass spectrometry confirmation
- GMP-certified sourcing, sterility screened
- Full 44-residue GHRH sequence — maximum GHRH receptor fidelity in research

## Shipping

- Standard Post: $8.99 AUD (2–6 business days)
- Express Post: $13.99 AUD (1–3 business days)
- Free shipping on orders over $199 AUD
- Orders placed before 12PM AEST dispatch the same business day; orders after 12PM AEST dispatch the next business day
- Discreet plain packaging, Australia Post tracking on every order

## Frequently Asked Questions

### What is Tesamorelin and what does the research show?

Tesamorelin (CAS 218949-48-9, MW ~5135 Da) is a synthetic GHRH analogue — the full 44-amino acid sequence of endogenous GHRH with a trans-3-hexenoic acid group at the N-terminus to improve DPP-IV resistance. It stimulates pituitary GHRH receptors to produce pulsatile GH release, which in turn increases hepatic IGF-1 production. Research has focused primarily on visceral adipose tissue biology via GH-stimulated lipolysis pathways, with clinical data from lipodystrophy trials. Secondary research areas include body composition, GH/IGF-1 axis characterisation, and emerging cognitive function data. For research use only.

### How is Tesamorelin different from GLP-1 compounds like Retatrutide?

Tesamorelin and GLP-1 compounds operate through entirely different mechanisms. GLP-1 research agonists act on incretin (GLP-1/GIP) and, for triple agonists, glucagon receptors. Tesamorelin instead stimulates the pituitary GHRH receptor to increase growth hormone output — it does not act on GLP-1, GIP, or glucagon receptors. Its downstream activity on lipid metabolism occurs via GH-stimulated lipolysis. In research, Tesamorelin is studied for adipose-tissue biology through this GH-axis mechanism, making it a distinct tool from the GLP-1 class. Not for human consumption — for research use only.

### How does Tesamorelin compare to CJC-1295?

Both Tesamorelin and CJC-1295 (no DAC) are GHRH analogues that stimulate pulsatile GH release. Key differences: Tesamorelin is the full 44-amino acid GHRH sequence with N-terminal fatty acid modification — most closely resembling endogenous GHRH in structure. CJC-1295 is a truncated 29-amino acid GHRH fragment with four amino acid substitutions. Tesamorelin is preferred when GHRH receptor fidelity to the full endogenous sequence is a research requirement. CJC-1295 is more commonly used in combination protocols with Ipamorelin. Not for human consumption — for research use only.

### How do I reconstitute and store Tesamorelin 10mg?

Reconstitution: Draw 1–2mL of bacteriostatic water into a clean 31G insulin syringe. Inject slowly down the inside wall of the Tesamorelin vial. Gently swirl until fully dissolved — do not shake or vortex. The solution should be clear and colourless. Common concentration: 1mL BAC water = 10mg/mL. Storage: Lyophilised — store at −20°C for up to 24 months. Reconstituted — refrigerate at 2–8°C and use within 28 days. Protect from light throughout.

### Is Tesamorelin legal to buy in Australia?

Tesamorelin is legal to purchase in Australia for legitimate laboratory research purposes. It is not listed as a scheduled substance under the Poisons Standard when sold for research use only. Purchasers must be 18+ and confirm research-only use. It is not TGA-approved for human consumption, therapeutic, or veterinary use. Our Tesamorelin 10mg is independently verified at 99.1% HPLC purity with full COA documentation. Peptide Warehouse Australia dispatches nationwide from our Melbourne warehouse via Australia Post.

### Where can I buy Tesamorelin in Australia?

Peptide Warehouse Australia stocks research-grade Tesamorelin 10mg and dispatches nationwide via Australia Post with full tracking from our Melbourne warehouse. Orders placed before 12PM AEST dispatch the same business day; orders after 12PM AEST dispatch the next business day. Standard Post (2–6 business days) $8.99; Express Post (1–3 business days) $13.99. Free shipping on orders over $199 AUD. Discreet plain packaging. For dual-pathway GH secretagogue research, also see our [CJC-1295 + Ipamorelin Blend](/products/cjc-1295-ipamorelin).

### What makes Tesamorelin a full-length GHRH analogue?

Tesamorelin is a synthetic analogue of the complete 44-amino-acid growth-hormone-releasing hormone, stabilised with an N-terminal modification, distinguishing it from shorter GHRH fragments such as CJC-1295 (Mod GRF 1-29). The full-length structure is central to its research profile. Not for human consumption — for research use only.

### What visceral-adipose research is Tesamorelin known for?

Tesamorelin has been studied in clinical and preclinical research for effects on visceral adipose tissue via growth-hormone-axis stimulation. This visceral-fat research angle is its most-cited area of investigation. Findings are from research settings; the compound is supplied strictly for research and is not TGA-approved. Not for human consumption — for research use only.

### How does Tesamorelin affect the GH/IGF-1 axis in research?

As a GHRH-receptor agonist, Tesamorelin is studied for stimulating endogenous growth-hormone release and downstream IGF-1 signalling in research models, rather than supplying growth hormone directly. This axis-stimulation mechanism is a key research variable. Not for human consumption — for research use only.

### How does Tesamorelin compare with CJC-1295 and Ipamorelin?

Tesamorelin is a full 44-residue GHRH analogue; CJC-1295 is a shorter modified GHRH fragment; Ipamorelin acts on the separate ghrelin/GHS receptor. All three are studied in growth-hormone-axis research but through different structures and receptors, and are distinct, non-interchangeable research tools. Not for human consumption — for research use only.

## Compliance

Sold strictly for in-vitro laboratory and research purposes only. Not for human consumption, therapeutic use, or veterinary use. Purchasers must be 18 years of age or older. See https://www.auspeptidewarehouse.com.au/legal for full terms.